Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print

Topics - Manufacturing


Refine by Date:
From: To:
Published October 20, 2014
Two other PR sites will support insulin and biologics portfolio Read More »
Published October 15, 2014
Increasing GMP issues may threaten patient safety unless QbD adoption grows Read More »
Published October 7, 2014
Offers a range of advanced biomedical technologies for clinical and commercial volumes Read More »
Published October 2, 2014
New Ireland site will produce packaging components for insulin injector cartridges Read More »
Published October 2, 2014
Aims to develop scalable and cost-effective process for a targeted API Read More »
Published October 2, 2014
Expands global footprint and product portfolio Read More »
Published October 1, 2014
Complies with excipient 
GMPs Read More »
Published September 30, 2014
Diversifies drug supply chain services Read More »
Published September 30, 2014
Will begin providing dedicated biologics services in the U.S Read More »
Published September 30, 2014
Expands capacity to produce APIs for diabetes drugs Read More »
Published September 30, 2014
Increases plasma processing and albumin production capacity to meet growing demand Read More »
Published September 25, 2014
Will align conjugation and manufacture of drug linkers with sterile fill/finish services Read More »
Published September 24, 2014
PBOA to represent CMO/CDMO interests Read More »
Published September 22, 2014
Expands growth platforms for Lab & Academia business pharma and biopharma production Read More »
Published September 15, 2014
India-based generic manufacturers to expand access to Hep C drugs Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On